Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vaxart, Inc. - Common Stock (NQ:VXRT)

0.3399 +0.0218 (+6.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vaxart, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows. 
Via Benzinga
3 Stocks That Have Analysts Running for the Exit
These are the three stocks analysts hate and avoid now because they could see significant declines in the coming months. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
Via Benzinga
Recap: Vaxart Q4 Earnings
Vaxart (NASDAQ:VXRT) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Vaxart... 
Via Benzinga
Vaxart Stock Crosses 2 Key Levels Friday: What's Next?
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... 
Via Benzinga
Vaxart Stock Breaks Out Of Pennant Pattern: Now What?
Vaxart Inc. (NASDAQ:VXRT) shares were trading higher ... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday, 721 companies achieved new lows for the year. 
Via Benzinga
VAXART ALERT: Bragar Eagel & Squire, P.C. is Investigating Vaxart, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Why Vaxart Stock Is About Ready To See A Breakout
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Wednes... 
Via Benzinga
Vaxart Stock Is Being Squeezed At The End Of A Pattern
Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Thursd... 
Via Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
Macy's Inc (NYSE:M) retail stores have something for everyo... 
Via Benzinga
Vaxart: Oral Covid-19 Vaccine Is Interesting, But Questions Linger
VXRT stock is more than a Covid-19 meme trade. But is there enough fundamentals there to support an investment heading into 2022? 
Via InvestorPlace
Wingstop, Akamai Initiations Among Today's Top Calls On Wall Street
Benchmark analyst Todd Brooks initiated coverage of Wingstop (WING) with a Hold rating and no price target. The analyst believes the stock's risk/reward is balanced at these levels given the current 
Via Talk Markets
Vaxart Deserves More Respect on Wall Street for Its Promising Covid-19 Vaccine
As the Covid-19 vaccine maker expands into a second manufacturing facility, VXRT stock remains an undervalued gem. 
Via InvestorPlace
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron
Vaxart Inc (NASDAQ: VXRT) plans to test the cross-reactivity of its oral tablet COVID-19 vaccine candidate against the omicron SARS-CoV-2 variant in two different... 
Via Benzinga
VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down
Despite a new factory acquisition, VXRT stock is down 9% on the day as 'Mad Money' host Jim Cramer warns investors about Vaxart. 
Via InvestorPlace
Cramer Gives His Opinion On Nokia, Delta Air Lines And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DigitalOcean Holdings, Inc. (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021
Upgrades UBS upgraded the previous rating for ONE Gas Inc (NYSE: 
Via Benzinga
Don’t Write Off Vaxart, As Its Oral Vaccine Still Has a Chance
Vaxart stock is still worth a shot, as there's still big potential demand for a "no-needle" Covid-19 vaccine alternative. 
Via InvestorPlace
Exposures COVID-19
Can This COVID Vaccine Stock Help Make You Rich?
This biotech has a nifty trick potentially up its sleeve. 
Via The Motley Fool
Exposures COVID-19
Why Ocugen Stock Is Rallying While Moderna, Novavax, Vaxart Can't Catch Up
Ocugen Inc. (NASDAQ:OCGN) shares were trading higher Tuesd... 
Via Benzinga
NASDAQ:VLDR Shareholder Notice: Update in Lawsuit Against Velodyne Lidar, Inc.
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Velodyne Lidar, Inc. (NASDAQ:VLDR). 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:VXRT Investor Alert: Update in Lawsuit Against Vaxart, Inc.
San Diego, CA -- (SBWIRE) -- 10/12/2021 -- An update was announced in the lawsuit that was filed for certain investors in shares of Vaxart, Inc. (NASDAQ:VXRT). 
Via SBWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
The company is working on a vaccine candidate that doesn't involve a needle. 
Via The Motley Fool
Why Vaxart Shares Are Trading Higher Today
Vaxart Inc (NASDAQ: VXRT) is trading higher Friday after the company reported a Duke University-led study published in bioRxiv showed that the company's investigational... 
Via Benzinga
18 Stocks Moving in Friday's Pre-Market Session
Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) rose 25.5% to $14.41 in pre-market trading after the company, in collaboration with investigators at Baylor College of Medicine... 
Via Benzinga
Why Vaxart Shares Are Surging In Thursday's After-Hours Session
Vaxart Inc (NASDAQ: VXRT) is surging higher in after-hours trading Thursday after the company reported a Duke University-led study published in bioRxiv showed that the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Vaxart (NASDAQ:VXRT) shares incr... 
Via Benzinga
Why Vaxart Stock Tumbled in September
A COVID-19 antiviral pill may undermine the biotech's value proposition. 
Via The Motley Fool
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback